Immunodiagnostic Systems Holdings plc provides earnings guidance for the six months ended 30 September 2013. Total revenues are expected to be £27 million representing 13% growth in revenues compared to the prior year equivalent period. The increase in revenue was driven by the continued growth in automated revenues of 37%, compared to the prior year period.
Immunodiagnostic Systems Holdings PLC
Equities
IDH
GB00B01YZ052
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-10.64% | 11.41B | |
-11.02% | 7.53B | |
+30.85% | 5.62B | |
-16.28% | 3.82B | |
+8.39% | 2.6B | |
-64.67% | 2.37B | |
-10.53% | 2.26B | |
+24.87% | 2.16B | |
-12.06% | 1.71B |